22nd Century Group Inc. (XXII) Starts Presentation at 12th Annual LD Micro Main Event
22nd Century (NYSE: XXII) is a plant biotechnology company aimed at reducing the harm caused by smoking. The company’s long-term focus is the research, development, licensing, manufacturing and worldwide sales and distribution of our important products. As a result of 22nd Century’s unique technology, the company is able to grow tobacco with up to 97% less nicotine than conventional tobacco – as well as plants with relatively high nicotine levels. The applications for this technology are extraordinary. For more information, visit the company’s website at www.xxiicentury.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our…







